Evidence map›Paper›PMID 27145783›Full record

ArticleInflammation2016

Fenton Reaction-Generated Advanced Oxidation Protein Products Induces Inflammation in Human Embryonic Kidney Cells.

Guilherme Vargas Bochi, Vanessa Dorneles Torbitz, Roberto Christ Vianna Santos, Monica Cubillos-Rojas, José Luis Rosa López, Anna Maria Siebel, Patrícia Gomes, Jarbas Rodrigues de Oliveira, Rafael Noal Moresco

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Current Use of Fenton Reaction in Drugs and Food.Molecules (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Guilherme Vargas BochiLaboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Federal University of Santa Maria, Santa Maria, Brazil. bochiguilherme@gmail.com.
Vanessa Dorneles TorbitzLaboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Federal University of Santa Maria, Santa Maria, Brazil.
Roberto Christ Vianna SantosResearch Laboratory of Clinical Microbiology, Franciscan University Center, Santa Maria, Brazil.
Monica Cubillos-RojasUnitat Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
José Luis Rosa LópezUnitat Bioquímica i Biologia Molecular, Departament de Ciències Fisiològiques II, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain.
Anna Maria SiebelLaboratório de Genética e Ecotoxicologia Molecular, Programa de Pós-Graduação em CiênciasAmbientais, Universidade Comunitária da Região de Chapecó, Chapecó, Brazil.
Patrícia GomesNanosciences Postgraduate Program, Franciscan University Center, Santa Maria, Brazil.
Jarbas Rodrigues de OliveiraResearch Laboratory of Cellular Biophysics and Inflammation, The Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Rafael Noal MorescoLaboratory of Clinical Biochemistry, Department of Clinical and Toxicological Analysis, Federal University of Santa Maria, Santa Maria, Brazil.
Universidade Federal de Santa Maria · BRInstitut d'Investigació Biomédica de Bellvitge · ESUniversidade Franciscana · BRCommunity University of Chapecó Region - Unochapecó · BRPontifícia Universidade Católica do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fenton reaction is a new mechanism able to generate advanced oxidation protein products (AOPPs) by exposing the human serum albumin to the Fenton system. Here, we characterized the effects of Fenton reaction-generated advanced oxidation protein products (AOPP-FR) on the gene transcription of the nuclear factor-κB (NF-κB), cyclooxygenase-2 (COX-2), and interleukin-6 (IL-6) in human embryonic kidney cells (HEK 293). To investigate the effects of AOPP-FR and AOPP-HOCl on transcription of inflammatory genes, the NF-κB, COX-2, and IL-6 luciferase promoter activities were analyzed. AOPP-FR and AOPP-HOCl were able to induce the activation of the gene transcription of NF-κB, COX-2, and IL-6 in HEK 293 cells. However, the effects of AOPP-FR were significantly higher than the effects of AOPP-HOCl in relation to COX-2 and IL-6. AOPP-FR induces the activation of the gene transcription of NF-κB, COX-2, and IL-6 and may represent a novel pathogenic mediator of inflammation in kidney.

Indexed as

Advanced Oxidation Protein ProductsCyclooxygenase 2HEK293 CellsHumansHydrogen PeroxideInflammationInterleukin-6IronNF-kappa BSerum AlbuminTranscriptional ActivationAdvanced Oxidation Protein ProductsCyclooxygenase 2Fenton's reagentHydrogen PeroxideIL6 protein, humanInterleukin-6IronNF-kappa BSerum Albuminadvanced oxidation protein productsfenton reactionHEK 293hypochlorous acid inflammation

Identifiers

PMID27145783
OpenAlexW2345340974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.